Descrizione del progetto
Un microchip innovativo per l’analisi di biomateriali in vivo
Il progetto IN2SIGHT, finanziato dall’UE, si propone di introdurre l’imaging ottico in vivo per l’innovativo test di biocompatibilità dei biomateriali. L’approccio si basa su un chip microstrutturato per l’impianto di tessuto di animali da laboratorio, caratterizzato da funzionalità rigenerative spontanee di tessuti vascolarizzati e da una serie di microlenti per l’imaging su punti multipli in situ. Tale tecnologia migliorerà nettamente la penetrazione della luce nei tessuti, limitando i problemi legati ad anomalie dell’immagine e consentendo analisi quantitative e longitudinali della risposta infiammatoria dell’ospite nell’impianto. Il progetto ha il potenziale per consentire di quantificare la reazione immunitaria nei confronti di biomateriali a livello cellulare, riducendo al contempo il numero di animali da laboratorio e, in generale, il costo della scoperta di tali materiali.
Obiettivo
Routine clinical use of biomaterials requires the reduction of the economical and ethical costs of biocompatibility tests (ISO10993 EU norm) which are unsustainable for small-medium industries and for the society. In this project we foster an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials.
A micro-structured chip, built by two-photon laser polymerization (2PP), will be implanted in lab animals, host a biomaterial and contain micro-features that guide the spontaneous regeneration of vascularized tissue within a thin gap (0.15mm) in contact with the biomaterial and act as beacons to correct the optical aberrations. The same chip carries a micro-lenses array for in-situ multi-spot imaging, with no need of external high numerical aperture objectives, dramatically improving light penetration in tissue. This chip will recast our thinking of deep tissue in-vivo imaging: the mice carry their own imaging optics, thus reducing substantially image aberration issues allowing unprecedented quantitative and longitudinal analyses of the host inflammatory response to the implant, without sacrificing the mice at each time step.
The project will allow unique quantification of the immune reaction to biomaterials at the cellular level (scientific impact), reduce (at least threefold) the number of used animals (societal impact) and the costs of biomaterial discovery (economical impact), and will Refine and Reduce protocols for biocompatibility on a single revolutionary device (regulatory impact). We open here a new visionary path for in-vivo imaging with high Replacement potential in oncological pharmaceutics and immune-therapies. 4 academic units, 1 public research institute and 2 SMEs ensure a highly inter-sectorial/interdisciplinary approach encompassing non-linear intravital imaging, bioengineering design, 2PP material science, biocompatibility protocols design and numerical simulations of immune response.
Campo scientifico
Programma(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-FETOPEN-2018-2019-2020-01
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
20126 MILANO
Italia